We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Rx DEVELOPMENT INSTITUTE PART OF FDA'S CRITICAL PATH PLAN
Rx DEVELOPMENT INSTITUTE PART OF FDA'S CRITICAL PATH PLAN
October 29, 2004
The University of Arizona (UA) is in talks with the FDA and private industry to establish a nonprofit institute that would help the agency and pharmaceutical companies expedite drug development while lowering costs.